Fixed-Duration or Continuous Therapy in CLL: Trial Says Take Your Pick

(MedPage Today) — ORLANDO — A year of combination therapy for previously untreated chronic lymphocytic leukemia (CLL) patients led to similar outcomes compared with indefinite BTK inhibition with ibrutinib (Imbruvica) alone, an interim analysis…

Source link : https://www.medpagetoday.com/meetingcoverage/ashhematology/118873

Author :

Publish date : 2025-12-07 13:22:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Fixed-Duration or Continuous Therapy in CLL: Trial Says Take Your Pick

What Did Trump’s MRI Assess?

Want Good Info on Epilepsy Treatment? Don’t Ask Dr. TikTok

Related Posts

HPV Vaccine Protection Extends to High-Grade Vulvovaginal Precancers

Flu cases falling ahead of Christmas, experts say

Deck the Halls With Ow’s From Folly: What the Numbers Tell Us About Holiday Injuries

Biosimilars Tip NICE Decision on Bowel Cancer Drug

Outbreak Hospitalizes 20; Former Senator’s ‘Death Sentence’; World’s Oldest Doc Dies

The Ins and Outs of Respiratory Virus Vaccines for Immunocompromised Patients

HPV Vaccine Protection Extends to High-Grade Vulvovaginal Precancers

Flu cases falling ahead of Christmas, experts say

Deck the Halls With Ow’s From Folly: What the Numbers Tell Us About Holiday Injuries

Biosimilars Tip NICE Decision on Bowel Cancer Drug

Outbreak Hospitalizes 20; Former Senator’s ‘Death Sentence’; World’s Oldest Doc Dies

The Ins and Outs of Respiratory Virus Vaccines for Immunocompromised Patients

High-Dose Buprenorphine for OUD With High Fentanyl Use?

Get Active: Leisure-Time Activity May Reduce Sleep Issues

Categories

Archives